1994
DOI: 10.1016/0014-2999(94)90202-x
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological profile of selective muscarinic receptor antagonists on guinea-pig ileal smooth muscle

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
24
0

Year Published

1994
1994
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(25 citation statements)
references
References 18 publications
1
24
0
Order By: Relevance
“…[3][4][5]7,9,12 Previous studies, including our own laboratory, have employed doses of atropine as much as 10,000 times or higher than theoretically required for binding at the M 4 receptors or 17,500 times or higher than required for binding at the M 1 receptor 5,43,44 based on published receptor affinity values. 45 Consequently, a number of studies have questioned whether muscarinic antagonist drug effects on myopia inhibition are working via retinal receptors and proposed either a nonreceptoral mechanism of action or at muscarinic receptors in the sclera. 16,46,47 The present study utilized highly selective muscarinic antagonists (MT3 and MT7) in an animal model that has both M 4 and M 1 receptors, and used doses to provide physiologically relevant concentrations at the receptor binding site for ocular-based receptors, specifically retinal-based receptors.…”
Section: Evidence For a Receptoral-based Mechanism Of Muscarinic Antamentioning
confidence: 99%
“…[3][4][5]7,9,12 Previous studies, including our own laboratory, have employed doses of atropine as much as 10,000 times or higher than theoretically required for binding at the M 4 receptors or 17,500 times or higher than required for binding at the M 1 receptor 5,43,44 based on published receptor affinity values. 45 Consequently, a number of studies have questioned whether muscarinic antagonist drug effects on myopia inhibition are working via retinal receptors and proposed either a nonreceptoral mechanism of action or at muscarinic receptors in the sclera. 16,46,47 The present study utilized highly selective muscarinic antagonists (MT3 and MT7) in an animal model that has both M 4 and M 1 receptors, and used doses to provide physiologically relevant concentrations at the receptor binding site for ocular-based receptors, specifically retinal-based receptors.…”
Section: Evidence For a Receptoral-based Mechanism Of Muscarinic Antamentioning
confidence: 99%
“…(Proska & Tuoek, 1994). About ten fold higher concentrations of alcuronium were needed to achieve the same slow rates of dissociation in the M4-like fraction as compared to the M2-like fraction (Table 5 (Tietje et al, 1990;Tietje & Nathanson, 1991) (Doods et al, 1994). -In cells transfected with chick genes, M4 receptors had a five fold lower affinity for AF-DX116 than the M2 receptors (Tietje & Nathanson, 1991).…”
Section: Effect Of Alcuronium On the Dissociation Of [3h]-nmsmentioning
confidence: 99%
“…On the other hand, the affinity of the M4 subtype for pirenzepine appeared 10 times (Waelbroeck et al, 1990;Lazarenio et al, 1990), 6 times (Wess et al, 1991) or 3 times higher (Doods et al, 1994) (Waelbroeck et al, 1990), 8 times lower (Ellis et al, 1991), or 7 times lower (Lazareno et al, 1990) receptors. The high affinity of chick cardiac receptors for pirenzepine has been observed repeatedly (Brown et al, 1985;Lindmar & Loffelholz, 1987;Jeck et al, 1988;Choo et al, 1988;Lazareno et al, 1990;Tietje & Nathanson, 1991), although low affinity was found by Sorota et al (1986).…”
Section: Effect Of Alcuronium On the Dissociation Of [3h]-nmsmentioning
confidence: 99%
“…This suggests that in the present study both the PTX-sensitive and PTX-insensitive G proteins may be linked to the M3 receptors which are thought to be the predominant receptors involved with contraction in this smooth muscle. However M2 receptors associated with PTXsensitive G proteins may also have a role in the agonist induced increases in the levels of inositol phosphates (Thomas et al, 1993 (Caulfield, 1993;Doods et al, 1994;Eglen et al, 1994).…”
Section: Toxin Treatmentmentioning
confidence: 99%